Preserved micturition after intradetrusor onabotulinumtoxinA injection for treatment of neurogenic bladder dysfunction in Parkinson’s disease

BACKGROUND: To assess the efficacy and safety of intradetrusor onabotulinumtoxinA (OnabotA) injection treatment in patients with neurogenic lower urinary tract dysfunction (NLUTD), especially for patients with Parkinson disease (PD). METHODS: PD patients refractory to oral antimuscarinic participate...

Descripción completa

Detalles Bibliográficos
Autores principales: Knüpfer, Stephanie C., Schneider, Susanne A., Averhoff, Mareike M., Naumann, Carsten M., Deuschl, Günther, Jünemann, Klaus-Peter, Hamann, Moritz F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011793/
https://www.ncbi.nlm.nih.gov/pubmed/27596481
http://dx.doi.org/10.1186/s12894-016-0174-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5011793/
https://www.ncbi.nlm.nih.gov/pubmed/27596481
http://dx.doi.org/10.1186/s12894-016-0174-2

Ejemplares similares